Graf Akcie JAGX (Jaguar Health Inc). Diskuze k akciím JAGX. Aktuální informace JAGX.

Základní informace o společnosti Jaguar Health Inc (Akcie JAGX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 276.01M
Hodnota podniku (EV) 310.97M
Tržby 6.975M
EBITDA -23.27
Zisk -45.73
Růst v tržbách Q/Q -87.84 %
Růst v tržbách Y/Y 7.05 %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 44.58
EV/EBITDA N/A
EV/EBIT N/A
PEG 0.00
Price/Sales 39.57
P/FCF N/A
Price/Book 16.05
Účetní hodnota na akcii 0.13
Hotovost na akcii 0.06
FCF vůči ceně -8.55 %
Počet zaměstnanců 34
Tržba na zaměstnance 205.147k
Profit margin -360.25 %
Operating margin -442.84 %
Gross margin 65.05 %
EBIT margin -526.18 %
EBITDA margin -333.58 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -65.52 %
EPS - Očekávaný růst příští rok -71.43 %
Return on assets -78.64 %
Return on equity -192.71 %
ROIC -89.44 %
ROCE -64.52 %
Dluhy/Equity 1.49
Čistý dluh/EBITDA -0.18
Current ratio 3.50
Quick Ratio 3.23
Volatilita 7.49
Beta 0.89
RSI 47.19
Cílová cena analytiků 5
Známka akcie (dle analytiků) N/A
Insider ownership 5.15 %
Institutional ownership 19.74 %
Počet akcií 137.329M
Procento shortovaných akcií 4.64 %
Short ratio 1.66 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země United States

Finanční výsledky akcie JAGX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$5.775$4.416$4.361$0.142$0.258--
Cost Of Goods Sold$3.816$2.766$0.88$0.052$0.124--
Gross Profit$1.959$1.65$3.481$0.09$0.135--
Research And Development Expenses$5.82$5.155$4.27$7.207$6.476$4.22$0.325
SG&A Expenses$20.439$22.109$14.331$6.469$6.104$4.095$0.459
Other Operating Income Or Expenses$-0.649------
Operating Expenses$34.723$35.24$38.608$13.728$12.704$8.316$0.783
Operating Income$-28.948$-30.824$-34.247$-13.586$-12.445$-8.316$-0.783
Total Non-Operating Income/Expense$-9.581$-1.322$-0.903$-1.148$-3.846$-0.294$-0.018
Pre-Tax Income$-38.539$-32.146$-35.15$-14.734$-16.292$-8.61$-0.801
Income Taxes$-0.01-$-13.181----
Income After Taxes$-38.529$-32.146$-21.969$-14.734$-16.292$-8.61$-0.801
Other Income-------
Income From Continuous Operations$-38.529$-32.146$-21.969$-14.734$-16.292$-8.61$-0.801
Income From Discontinued Operations-------
Net Income$-44.726$-32.146$-21.969$-14.734$-16.638$-9.256$-0.801
EBITDA$-21.863$-23.097$-16.235$-13.028$-9.72$-8.118$-0.78
EBIT$-28.948$-30.824$-34.247$-13.586$-12.445$-8.316$-0.783
Basic Shares Outstanding5000000
Shares Outstanding5000000
Basic EPS$-9.01$-153.27$-530.77$-1415.38$-2830.75$-3396.90$-314.53
EPS - Earnings Per Share$-9.01$-153.27$-530.77$-1415.38$-2830.75$-3396.90$-314.53
# 2020 2019 2018 2017 2016 2015
Current Ratio0.61860.30570.24690.60942.16331.0208
Long-term Debt / Capital0.0214-0.3888-2.85480.4821-
Debt/Equity Ratio0.35141.11830.9504-1.58391.3532-0.8779
Gross Margin33.928337.371979.812763.280952.219-
Operating Margin-501.2437-697.9836-785.2694-9599.842-4816.674-
EBIT Margin-501.2437-697.9836-785.2694-9599.842-4816.674-
EBITDA Margin-378.5557-523.0179-372.2694-9205.857-3761.711-
Pre-Tax Profit Margin-667.3198-727.9213-805.9701-10410.87-6305.243-
Net Profit Margin-774.4459-727.9213-503.7303-10410.87-6439.298-
Asset Turnover0.15860.10760.10.03970.0208-
Inventory Turnover Ratio1.79260.82750.42470.12590.5371-
Receiveable Turnover3.40814.40829.298228.51564.6249-
Days Sales In Receivables107.098882.800139.255112.878.9201-
ROE - Return On Equity-429.941-597.1643-127.2731600.3531-370.3385104.5454
Return On Tangible Equity706.2028185.5212102.9118600.3533-370.3385925.4283
ROA - Return On Assets-105.8198-78.3249-50.353-413.5045-131.3286-194.7884
ROI - Return On Investment-183.316-223.4986-77.78312314.234-191.7979925.4285
Book Value Per Share0.37690.353825.7931-183.6963567.647-339.3831
Operating Cash Flow Per Share104.262128.88431142.65181059.347-470.825-1836.7946
Free Cash Flow Per Share104.2931128.85321152.62881049.83-451.029-1857.0506